Condition
Alzheimer Disease and Related Dementias
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed with results
Key Signals
3 with results75% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (6)
Trial Status
Completed3
Not Yet Recruiting1
Terminated1
Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05618834Not ApplicableCompletedPrimary
Promoting Positive Care Interactions (PPCI) in Assisted Living
NCT05847153Not ApplicableCompletedPrimary
MASC: Reducing Stress for Caregivers
NCT06821568Not ApplicableRecruitingPrimary
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
NCT07182357Not ApplicableNot Yet RecruitingPrimary
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
NCT04855643Not ApplicableTerminatedPrimary
Home-based tDCS for Apathy in Alzheimer's Disease
NCT04938648Not ApplicableCompleted
Aligning Medications With What Matters Most
Showing all 6 trials